COGT — Cogent Biosciences Inc. stock price and chart

Share this page

COGT

$29.52+0.03%

as of close, Oct 16, 2026

☾ AH $29.52 +0.03%

Cogent Biosciences Inc.Stock · HealthcareRussell 2000 0.2%Nasdaq Composite 0.01%Russell 3000 0.009%US Stock Market 0.009%

PeersMRNALLYMDTUNHJNJTMO

Technical analysis2

Overlay lines0

Addendum charts0

Available history since Apr 5, 2018

VolumeSEEEE

20182020202220242026

10.020.030.040.050.060.0050.0M100.0M$29.52

2026-10-16

Price$29.52

MA20$35.45

MA50$34.89

Vol13.0M

What would $1,000 invested in COGT be worth today? →

COGT returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $29.52
YTD price return: -16.89%
YTD total return: -16.89%
Next earnings: Nov 6, 2026
Market cap: 5.1B2018-03 113.3M2026-10 5.1B+4421.0% over the window
Enterprise value: 5.2B
Shares outstanding: 173.5M2017-12 2.6M2026-06 173.5M+6703.8% over the window
52W low: $13.78
52W high: $43.73
From 52W high: -32.49%
From 52W low: +114.22%
52W range: 53%

Volume

Rel volume: 1.26×
30D volume: 2.2M
30D $ vol: 69.3M

Fundamentals

EPS (ttm): -$2.432018-09 -$0.002026-06 -$2.43+55563.2% over the window
FCF (ttm): -309.2M2017-12 -26.7M2026-06 -309.2M+1056.2% over the window
FCF/share: -$1.782017-12 -$10.492026-06 -$1.78-83.0% over the window
Book value/share: $3.072017-12 -$19.152026-06 $3.07-116.0% over the window
ROE: -70.85%2018-09 -48.3%2026-06 -70.8%+46.7% over the window
ROA: -45.20%2017-12 -51.9%2026-06 -45.2%-12.9% over the window
Debt / equity: 0.42×2024-12 0.002026-06 0.42
Current ratio: 13.572017-12 3.792026-06 13.57+258.4% over the window

Growth (CAGR, ttm) · 10Y

Sales: -64.94%2019-12-31 → 2020-12-3122.5M → 7.9M (-65.0% total)-1.99%2017-12-31 → 2020-12-318.4M → 7.9M (-5.8% total)n/an/a
Shares: +24.23%2025-06-30 → 2026-06-30139.7M → 173.5M (+24.2% total)+26.62%2023-06-30 → 2026-06-3085.5M → 173.5M (+103.0% total)+34.22%2021-06-30 → 2026-06-3039.8M → 173.5M (+335.5% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Sales/share: -92.76%2019-12-31 → 2020-12-31$2.94 → $0.21 (-92.8% total)-59.88%2017-12-31 → 2020-12-31$3.28 → $0.21 (-93.5% total)n/an/a
Book value/share: +176.65%2025-06-30 → 2026-06-30$1.11 → $3.07 (+176.5% total)-9.04%2023-06-30 → 2026-06-30$4.08 → $3.07 (-24.7% total)-10.49%2021-06-30 → 2026-06-30$5.34 → $3.07 (-42.5% total)n/a
Price: +80.51%2025-10-16 → 2026-10-16$16.36 → $29.52 (+80.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+46.22%2023-10-16 → 2026-10-16$9.44 → $29.52 (+212.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+26.14%2021-10-15 → 2026-10-16$9.24 → $29.52 (+219.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a
Total return: +80.51%2025-10-16 → 2026-10-16$16.36 → $29.52 (+80.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+46.22%2023-10-16 → 2026-10-16$9.44 → $29.52 (+212.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+26.14%2021-10-15 → 2026-10-16$9.24 → $29.52 (+219.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: -12.1×2018-03 -4.452026-10 -13.59+205.6% over the window
Fwd P/E: -27.6×
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 9.6×2018-03 -2.322026-10 9.62-514.8% over the window
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: -6.04%2017-12 -23.6%2026-06 -4.6%-80.5% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 173.5M ÷ 139.7M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -24.23%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-24.23%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($1B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -24.23%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($5.1B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.00%2017-12 -0.1%2026-06 0.0%-100.0% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($5.1B). Same caveat as the cash buyback yield.: 0.00%2017-12 -0.1%2026-06 0.0%-100.0% over the window

Vs own 10Y history

P/S: 90th
P/B: 89th

Bar = where today’s multiple sits in COGT’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-16#

+0.03%

-4.77%

-9.28%

-22.19%

YTD

-16.89%

+80.44%

+219.48%

Financial statements

Open full COGT financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+10.48%	+0.43%
JNJ	Johnson & Johnson	-4.38%	+0.90%
ABBV	AbbVie Inc.	+8.73%	+0.71%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+6.97%	-1.29%
MRK	Merck & Co. Inc.	+0.72%	+0.52%
NVS	Novartis AG	+8.59%	+0.16%
TMO	Thermo Fisher Scientific Inc.	+6.41%	-0.93%
AMGN	Amgen Inc.	+14.92%	-0.35%

COGT — Cogent Biosciences Inc. price, chart and key statistics